Aidoc eyes IPO following Goldman-led $150M raise
Radiology is one of AI's earliest and most established use cases at scale in health care.
TL;DR
- Aidoc raised $150 million in Series E funding, led by Goldman Sachs Alternatives.
- The company has raised $520 million to date.
- Proceeds will support regulatory approval processes and investment in a comprehensive AI model.
- Aidoc's AI flags incidental findings on CT scans and X-rays for use cases like emergency department triage and identifying abnormalities.
- The company aims to IPO in three to five years.
- Aidoc faces competition from companies like GE HealthCare and Siemens Healthineers.
- The company has received 31 FDA clearances and is deployed in nearly 200 U.S. health systems and over 1,600 hospitals worldwide.